AF
HARP

Amalgamated Financial’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Amalgamated Financial’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$15K Buy
+305
New +$15.8K ﹤0.01% 2823

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Amalgamated Financial's HARP Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2022: 305 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #2823 among its holdings.

79 funds tracked by Wall St. Rank hold HARP as of Q1 2022.

  • Amalgamated Financial held 305 shares of Harpoon Therapeutics, Inc. Common Stock worth $15K as of Q1 2022.
  • Harpoon Therapeutics, Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
  • Harpoon Therapeutics, Inc. Common Stock made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2823 holding.
  • 79 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.